Skellefteå, Sweden

Kurt Lundström

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Kurt Lundström in Pharmaceutical Analysis**

Introduction

Kurt Lundström, an inventive mind hailing from Skellefteå, Sweden, has made significant strides in the field of pharmaceutical analysis. With a focus on enhancing the methods of analyzing solid dosage forms, such as tablets, pellets, and capsules, Lundström's inventive spirit is reflected in his patent, which addresses critical aspects of sample presentation in pharmaceutical equipment.

Latest Patents

Lundström holds a notable patent titled "Apparatus and method for analysing." This innovative invention revolves around a sample presentation apparatus tailored for analyzing equipment used in pharmaceutical products. The patent outlines a method for presenting samples to analysis equipment, where samples are sequentially fed through designated analyzing positions. At these positions, they are subjected to measuring radiation beams that irradiate the samples. A distinguishing feature of this invention is the inclusion of a two-piece means designed to temporarily fix each sample at the analyzing position, thereby enhancing the accuracy and efficiency of the analysis.

Career Highlights

Kurt Lundström is affiliated with AstraZeneca AB, a leading global biopharmaceutical company known for its dedication to innovation and improving patient outcomes. His work at AstraZeneca signifies his commitment to advancing pharmaceutical technology and contributing to the company's mission of pushing the boundaries in drug development and analysis.

Collaborations

Throughout his career, Lundström has collaborated with esteemed colleagues such as Staffan Folestad and Göran Östling. These partnerships have likely fostered an environment of shared knowledge and expertise, enabling innovative solutions to emerge within the realm of pharmaceutical analysis.

Conclusion

In summary, Kurt Lundström's contributions to the field of pharmaceutical analysis through his patented invention demonstrate his innovative approach to solving complex challenges in drug analysis. His role at AstraZeneca AB and collaboration with fellow experts highlight the importance of teamwork in fostering innovation. As the pharmaceutical industry evolves, Lundström's work will undoubtedly play a vital role in shaping the future of drug analysis and contributing to the advancement of public health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…